Europe Dental Biomaterials Market

Europe Dental Biomaterials Size (2022 to 2027)

The size of the dental biomaterials market in the European region is predicted to expand at a CAGR of 6.3% from 2022 to 2027 and be worth USD 3.6 billion by 2027 from USD 2.65 billion in 2022.

The primary factors driving the growth of the dental biomaterials market in Europe are the rising frequency of dental problems, rising expenditure on dental and oral care, a growing number of dental clinics, increased adoption of novel adhesives, and the growing dental tourism in this region. Furthermore, in the forecasted period, rising shifts toward newer materials and products, rising growth in this country, rising modernization and technological advancements in the healthcare sector, and increasing research and development activities in the market create new opportunities for the European dental biomaterials market. According to The Platform for Better Oral Health in Europe, more than half of the European population has periodontitis. Furthermore, more than ten percent of the population has serious illnesses, with the significant prevalence rising to 70-85 percent of the population aged 60-65 years old. As a result, increased oral problems are propelling the market's rise.

Dental disorders such as tooth decay and periodontal diseases are becoming more common due to factors such as changing eating habits and lifestyles, tobacco use, smoking, and poor oral health. The demand for biomaterials for tissue engineering and numerous regenerative periodontal therapies, including the use of bone grafts, barrier membranes, and combination procedures to treat periodontal disorders, has surged as a result. As a result, the market expansion is likely to be fueled by the rising prevalence of dental problems over the forecast period.

On the other hand, Dental Biomaterials require complex regulatory approval processes, which might be one of the primary restraints on the market's growth during the forecast period. Increasingly demanding regulatory and clinical processes and large-scale acquisitions of dental biomaterials are among the main obstacles to market progress. In contrast, a growing scarcity of dental professionals will further stymie market expansion in the forecast future.

This research report on the European dental biomaterials market has been segmented and sub-segmented into the following categories.

By Type:

• Metallic Biomaterials
  • Titanium
  • Stainless Steel
  • Chromium Alloys
  • Others
• Ceramic Biomaterials
• Polymeric Biomaterials
• Metal-Ceramic Biomaterials
• Natural Biomaterials
• Composites Biomaterials

By Application:

• Implantology
• Orthodontics
• Prosthodontics

By End-User:

• Dental Implant and Prosthetic Manufacturers
• Dental Laboratories
• Dental Hospitals & Clinics
• Dental Academics & Research Institutes

By Country:

• UK
• France
• Spain
• Germany
• Italy
• Russia
• Sweden
• Denmark
• Switzerland
• Netherlands
• Turkey
• Czech Republic
• Rest of Europe

In the worldwide dental biomaterials market, Europe holds a significant position. The expanding senior population, increasing government investment in oral healthcare, higher usage of dental biomaterials to make implants and other dental products, and the increased acceptance of dental biomaterials in the production of implants and other dental products are the main reasons for Europe's supremacy. Due to rising per capita income expenditure and improved healthcare infrastructure, Europe is the second-largest contributor to the market. Due to the presence of well-established players offering dental bone graft substitutes and increased penetration of dental implants in the region. Due to the existence of established economies, an increasing number of dental treatments, and rising government support, Western Europe is expected to lead the market. In the near future, favorable government policies and incentives, and favorable laws are expected to determine the growth of the dental biomaterials market. In addition, customers' spending capacity will rise in pace with their disposable income, boosting the market for dental biomaterials even more.

KEY MARKET PLAYERS:

Companies playing an influential role in the European dental biomaterials market profiled in this report are Straumann Holding AG, Geistlich Pharma AG, Zimmer Biomet Holdings, Inc., Danaher Corporation, Dentsply Sirona, Inc., 3M Company, Royal DSM, Carpenter Technology Corporation, Kuraray Co., Ltd., and Henry Schein, Inc.